olopatadine (Patanol, Pataday)
Jump to navigation
Jump to search
Introduction
Tradenames: Patanol.
Indications
Dosage
1-2 drops BID
Ophthalmic: 0.1% (Pataday) Nasal spray 0.4%, 0.6%
More general terms
Component of
References
- ↑ Kamis U, Ozturk BT, Ozkagnici A, Gunduz K. Comparison of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and artificial tears in seasonal allergic conjunctivitis. Acta Ophthalmol Scand. 2006 Feb;84(1):148-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16445458
- ↑ Meltzer EO, Hampel FC, Ratner PH, Bernstein DI, Larsen LV, Berger WE, Finn AF Jr, Marple BF, Roland PS, Wall GM, Brubaker MJ, Dimas C, Potts SL, Silver LH, Barnes JR. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2005 Dec;95(6):600-6. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16400902
- ↑ Hampel FC Jr, Ratner PH, Amar NJ, van Bavel JH, Mohar D, Fairchild CJ, Wall GM, Brubaker MJ, Drake M, Crenshaw KM. Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo. Allergy Asthma Proc. 2006 May-Jun;27(3):202-7. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16913262
- ↑ Prescriber's Letter 15(6): 2008 Nasal Sprays for Allergic Rhinitis Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=240609&pb=PRL (subscription needed) http://www.prescribersletter.com
Database
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5284599
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=60864
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=60865
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5281071
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5282402